Neoadjuvant Herceptin in Patients With Breast Cancer
Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to better understand how Herceptin causes tumors to become
smaller and to find out how effective Herceptin, together with chemotherapy, is in treating
advanced breast cancer.